These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18354200)

  • 21. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells.
    Benkhoucha M; Molnarfi N; Dunand-Sauthier I; Merkler D; Schneiter G; Bruscoli S; Riccardi C; Tabata Y; Funakoshi H; Nakamura T; Reith W; Santiago-Raber ML; Lalive PH
    J Immunol; 2014 Sep; 193(6):2743-52. PubMed ID: 25114100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N; Ehlers S; Hölscher C
    Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
    Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
    Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity.
    Hartman ZC; Osada T; Glass O; Yang XY; Lei GJ; Lyerly HK; Clay TM
    Cancer Res; 2010 Sep; 70(18):7209-20. PubMed ID: 20823152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.
    Subramanian M; Thorp E; Hansson GK; Tabas I
    J Clin Invest; 2013 Jan; 123(1):179-88. PubMed ID: 23257360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
    Derkow K; Krüger C; Dembny P; Lehnardt S
    PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.
    Asquith MJ; Boulard O; Powrie F; Maloy KJ
    Gastroenterology; 2010 Aug; 139(2):519-29, 529.e1-2. PubMed ID: 20433840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory B cells in infection, inflammation, and autoimmunity.
    Dasgupta S; Dasgupta S; Bandyopadhyay M
    Cell Immunol; 2020 Jun; 352():104076. PubMed ID: 32143836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.
    Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H
    J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines.
    Zhu Q; Egelston C; Vivekanandhan A; Uematsu S; Akira S; Klinman DM; Belyakov IM; Berzofsky JA
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16260-5. PubMed ID: 18845682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation.
    Tsai HC; Nguyen K; Hashemi E; Engleman E; Hla T; Han MH
    J Autoimmun; 2019 Dec; 105():102290. PubMed ID: 31202617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B Cell-Extrinsic
    Sweet RA; Nickerson KM; Cullen JL; Wang Y; Shlomchik MJ
    J Immunol; 2017 Aug; 199(3):885-893. PubMed ID: 28659358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.
    Lee MSJ; Natsume-Kitatani Y; Temizoz B; Fujita Y; Konishi A; Matsuda K; Igari Y; Tsukui T; Kobiyama K; Kuroda E; Onishi M; Marichal T; Ise W; Inoue T; Kurosaki T; Mizuguchi K; Akira S; Ishii KJ; Coban C
    Eur J Immunol; 2019 Sep; 49(9):1433-1440. PubMed ID: 31087643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
    Lee SY; Goverman JM
    J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
    Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
    Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.